950
Participants
Start Date
April 30, 1999
Primary Completion Date
July 31, 2007
fluorouracil
Given IV or orally
eniluracil
Given orally
Eastern Cooperative Oncology Group, Boston
National Cancer Institute (NCI)
NIH